Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ELCC 2019 | The LUNAR study: TTFields for NSCLC

Here Ori Farber, MD, of Novocure, Haifa, Israel, gives a background of the ongoing LUNAR study (NCT02973789) using tumor treating fields (TTF) to treat patients with non-small cell lung cancer (NSCLC) following progression while on or after platinum based treatment. This video was recorded at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.